Tag Archives: APHQF

Best Bank Stocks To Invest In 2019

Get ready to feel the pain, says one famed investor. 

Jim Rogers says market participants should enjoy the rally in stocks while it lasts, issuing a dire warning that “the worst correction of his lifetime” is coming.   U.S. stocks opened higher on Monday as the corporate earnings season continued, with Bank of America ( BAC) reporting better-than-expected quarterly results. The Dow Jones Industrial Average rose 182 points, or 0.75%, to 24,542, the S&P 500 was up 0.6% and the Nasdaq rose 0.35%. Leading the Dow higher were Merck & Co. ( MRK)  and Action Alerts PLUS holding UnitedHealth Group Inc. ( UNH) .  

Best Bank Stocks To Invest In 2019: Ormat Technologies, Inc.(ORA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Logan Wallace]

    Aura Minerals Inc (TSE:ORA) insider Enterprises Ltd. Northwestern acquired 11,600 shares of Aura Minerals stock in a transaction that occurred on Wednesday, August 1st. The stock was purchased at an average cost of C$2.10 per share, with a total value of C$24,360.00.

  • [By Shane Hupp]

    JPMorgan Chase lowered shares of Ormat Technologies (NYSE:ORA) from an overweight rating to a neutral rating in a research note issued to investors on Monday, MarketBeat.com reports. They currently have $62.00 price target on the energy company’s stock.

  • [By Max Byerly]

    JPMorgan Chase & Co. lessened its stake in shares of Ormat Technologies, Inc. (NYSE:ORA) by 9.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 225,381 shares of the energy company’s stock after selling 23,000 shares during the period. JPMorgan Chase & Co.’s holdings in Ormat Technologies were worth $12,708,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Roth Capital set a $67.00 price target on Ormat Technologies (NYSE:ORA) in a report issued on Sunday. The brokerage currently has a buy rating on the energy company’s stock.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

Best Bank Stocks To Invest In 2019: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Keith Speights]

    The stock market itself could provide a big clue as to which Canadian marijuana growers are most likely to follow in Canopy’s footsteps. Investors bid up the share prices of three stocks in particular: Tilray (NASDAQ:TLRY), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF).

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed this week:

    22nd Century Group Inc (NYSE: XXII): down 9 percent
    Aphria Inc (OTC: APHQF): down 8.6 percent
    Aurora Cannabis Inc (OTC: ACBFF): down 11.4 percent
    Cannabis Sativa Inc (OTC: CBDS): down 10.4 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 2.8 percent
    Canopy Growth Corp (OTC: TWMJF): down 7.8 percent
    Cronos Group Inc. (NASDAQ: CRON): down 7.7 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.5 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 10.8 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 6.2 percent
    MassRoots Inc (OTC: MSRT): down 6.2 percent
    MedReleaf Corp(OTC: MEDFF): up 0.5 percent
    Scotts Miracle-Gro Co (NYSE: SMG): up 2 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 3.8 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): down 1.7 percent
    In The News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Todd Campbell]

    Horizons Marijuana Life Sciences Index ETF

    Company Percent of Holdings
    Canopy Growth Corp. 11.65%
    Aurora Cannabis Inc. 11.62%
    Tilray, Inc. 9.59%
    Aphria Inc. (NASDAQOTH: APHQF) 9.24%
    GW Pharmaceuticals PLC 8.94%
    Scotts Miracle-Gro Co. (NYSE:SMG) 7.44%
    Cronos Group Inc. 5.72%
    Hexo Corp. 4.03%
    Green Organic Dutchman Holding 3.78%
    CannTrust Holdings 2.82%

    Data source: ETFMJ and Horizons ETFs.

  • [By ]

    The three companies we consider most potent for future growth in value are Canopy Growth Corp. (NYSE:CGC), Aurora Cannabis (OTCQX:ACBFF), and Aphria (OTCQB:APHQF). Canopy is a diversified cannabis company that both produces and sells cannabis products for the Canadian medical cannabis market. The company is well-positioned to start growing for recreational use once it becomes legal. Aurora’s focus is also on both growing and selling medical cannabis and produces both psychoactive THC products and medically oriented CBD products. It has an aggressive growth and acquisition strategy, also having conducted the largest acquisition in the cannabis industry when acquiring CanniMed Therapeutics earlier this year. Aphria is another grower and seller of medical marijuana, which conducts its sales through retail stores and wholesale distribution. All three companies have well-positioned themselves in the Canadian market and could be potential target companies for Big Tobacco or Big Alcohol or turn into major market leaders.

  • [By ]

    Here is the list of the cannabis companies that we track.

    Name Currency Ticker Canopy Growth Corp. CAD (CGC) Aurora Cannabis Inc. CAD (ACBFF) Aphria Inc. CAD (APHQF) MedReleaf Corp. CAD (OTCPK:MEDFF) Cronos Group CAD (CRON) The Green Organic Dutchman CAD (OTC:TGODF) CannTrust CAD (OTC:CNTTF) Hydropothecary Corp/The CAD (HYYDF) Cannabis Wheaton Income CAD (OTCQB:CBWTF) Emerald Health Therapeutics Inc. CAD (OTCQX:EMHTF) Organigram Holdings Inc. CAD (OTCQB:OGRMF) TerrAscend Corp. CAD (OTC:TRSSF) Supreme Cannabis Co Inc./The CAD (OTCPK:SPRWF) Hiku Brands CAD (OTCPK:DJACF) ABcann Global Corp. CAD (OTCQB:ABCCF) Radient Technologies Inc. CAD (OTC:RDDTF) Village Farms International Inc. CAD (OTCQX:VFFIF) Namaste Technologies CAD (OTCQB:NXTTF) MPX Bioceutical Corp. CAD (OTCQB:MPXEF) Sunniva CAD (OTCQX:SNNVF) MYM Nutraceuticals Inc. CAD (OTCQB:MYMMF) Maricann Group Inc. CAD (OTCQB:MRRCF) Cannabix Technologies Inc. CAD (OTCPK:BLOZF) THC Biomed INTL. Ltd. CAD (OTCQB:THCBF) ICC Labs Inc. CAD (OTC:ICCLF) WeedMD Inc. CAD (OTCPK:WDDMF) CannaRoyalty Corp. CAD (OTCQX:CNNRF) InMed Pharmaceuticals Inc. CAD (OTCQX:IMLFF) Harvest One Cannabis Inc. CAD (OTC:HRVOF) Golden Leaf Holdings Inc. CAD (OTCQB:GLDFF) Benchmark Botanics Inc. CAD (OTCPK:BHHKF) Friday Night Inc. CAD (OTCQB:TGIFF) Valens Groworks Corp. CAD (OTC:MYMSF) Invictus MD CAD (IVITF) Emblem Corp. CAD (OTCPK:EMMBF) Tetra Bio-Pharma Inc. CAD (OTCQB:TBPMF) Maple Leaf Green World Inc. CAD (OTCQB:MGWFF) Delta 9 Cannabis Inc. CAD (OTC:VRNDF) Nutritional High International Inc. CAD (OTCQB:SPLIF) Lifestyle Delivery Systems Inc. CAD (OTCQX:LDSYF) Marapharm Ventures Inc. CAD (OTCQX:MRPHF) Wildflower Marijuana Inc. CAD (OTC:WLDFF) Indiva Ltd. CAD (OTC:RMKXD) Hempco Food And Fiber Inc. CAD (OTC:HMPPF) PUF Ventures Inc. CAD (OTCPK:PUFXF) Liberty Leaf Holdings CAD (OTCQB:LIBFF) Canada House Welln

  • [By Sean Williams]

    According to BNN Bloomberg, Ontario-based Aphria (NASDAQOTH:APHQF) was, at one time, the apple of Coke’s eye. A source familiar with the matter notes that Coca-Cola held talks with senior management at Aphria a few months ago, but that no agreement was reached. The thing is, Aphria has just as much of a pedigree as a partner as Aurora Cannabis does. 

Best Bank Stocks To Invest In 2019: support.com Inc.(SPRT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Support.com (NASDAQ: SPRT) and iPass (NASDAQ:IPAS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Best Tech Stocks To Watch Right Now

Bristol-Myers Squibb (NYSE:BMY) is a global biopharmaceutical company with leading franchises in oncology, immunoscience and cardiovascular drugs. Long-time shareholders may recall a successful Bristol-Myers Squibb investment that we sold in 2013. We got another opportunity to own this company during the past quarter when investors became fearful that a competing drug would take share in the cancer market. We believe these fears are overstated because cancer remains a dangerous disease that is difficult to treat. The company’s two most valuable drugs Opdivo and Yervoy should continue to grow revenue as they maintain effectiveness with new tumor types. Bristol Myers Squibb also has the most new molecular agents and the highest number of combinations of agents in trials. Moreover, the company’s R&D and marketing prowess also make it a desired partner for promising academic and small biotech innovators. Collectively, these assets should assure Bristol-Myers Squibb’s oncology leadership for many years. We believe intrinsic value is closer to the $70 level it traded for earlier this year than its more recent price in the low $50s.

Best Tech Stocks To Watch Right Now: Nordson Corporation(NDSN)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Nordson (NASDAQ:NDSN) Q2 2018 Earnings Conference CallMay. 22, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Nordson Corporation(NASDAQ:NDSN)announced solid fiscal second-quarter 2018 results on Monday after the market closed, including an expected decline in organic volume that was more than offset by acquisitive growth.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nordson (NDSN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Victory Capital Management Inc. grew its stake in shares of Nordson Co. (NASDAQ:NDSN) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,868 shares of the industrial products company’s stock after purchasing an additional 1,612 shares during the period. Victory Capital Management Inc.’s holdings in Nordson were worth $2,300,000 as of its most recent SEC filing.

  • [By Garrett Baldwin]

    Markets have been under pressure once again by the U.S. Federal Reserve. Inflation levels are going through the roof… but the people in charge of managing it have been lying to Americans for years. Now, it’s time to get even.Money MorningLiquidity Specialist Lee Adler has the perfect way to make a lot of money when no one is looking.Read it here.

    The Top Stock Market Stories for Monday
    Markets are cheering news that the supposed trade war between the United States and China is “on hold,” according to U.S. Treasury Secretary Steven Mnuchin. Mnuchin and U.S. President Donald Trump’s top economic advisor, Larry Kudlow, announced that both nations have reached an agreement, one that established a framework to help address ongoing trade imbalances between the two countries. The prices of crude oil is in focus after Venezuelan President Nicolas Maduro won reelection over the weekend. The election featured a very low turnout and a very large outcry that the vote was rigged. Maduro has a 75% disapproval rating and has been the face of the OPEC member’s widespread mismanagement and economic collapse. Prior to the election, a member of the Trump administration said that the United States would not recognize the authenticity of the election. The United States is considering additional sanctions on Venezuela. Today is a major day for mergers and acquisition activity. Today, Blackstone Group LP(NYSE: BX) announced plans to purchase U.S. hotel operator LaSalle Hotel Properties (NYSE: LHO) for a whopping $3.7 billion. The deal comes at a time that the travel industry is experiencing one of the best periods in a decade. If you’re looking for a way to make money ahead of Memorial Day weekend, we show you how here.
    Four Stocks to Watch Today: GOOGL, GE, MBFI, FITB
    Alphabet Inc. (Nasdaq: GOOGL) is under pressure this morning after a harsh piece aired last night on “60 Minutes.” The segment discussed the organization’s power and influence. It also featured inter

Best Tech Stocks To Watch Right Now: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By ]

    Here is the list of the cannabis companies that we track.

    Name Currency Ticker Canopy Growth Corp. CAD (CGC) Aurora Cannabis Inc. CAD (ACBFF) Aphria Inc. CAD (APHQF) MedReleaf Corp. CAD (OTCPK:MEDFF) Cronos Group CAD (CRON) The Green Organic Dutchman CAD (OTC:TGODF) CannTrust CAD (OTC:CNTTF) Hydropothecary Corp/The CAD (HYYDF) Cannabis Wheaton Income CAD (OTCQB:CBWTF) Emerald Health Therapeutics Inc. CAD (OTCQX:EMHTF) Organigram Holdings Inc. CAD (OTCQB:OGRMF) TerrAscend Corp. CAD (OTC:TRSSF) Supreme Cannabis Co Inc./The CAD (OTCPK:SPRWF) Hiku Brands CAD (OTCPK:DJACF) ABcann Global Corp. CAD (OTCQB:ABCCF) Radient Technologies Inc. CAD (OTC:RDDTF) Village Farms International Inc. CAD (OTCQX:VFFIF) Namaste Technologies CAD (OTCQB:NXTTF) MPX Bioceutical Corp. CAD (OTCQB:MPXEF) Sunniva CAD (OTCQX:SNNVF) MYM Nutraceuticals Inc. CAD (OTCQB:MYMMF) Maricann Group Inc. CAD (OTCQB:MRRCF) Cannabix Technologies Inc. CAD (OTCPK:BLOZF) THC Biomed INTL. Ltd. CAD (OTCQB:THCBF) ICC Labs Inc. CAD (OTC:ICCLF) WeedMD Inc. CAD (OTCPK:WDDMF) CannaRoyalty Corp. CAD (OTCQX:CNNRF) InMed Pharmaceuticals Inc. CAD (OTCQX:IMLFF) Harvest One Cannabis Inc. CAD (OTC:HRVOF) Golden Leaf Holdings Inc. CAD (OTCQB:GLDFF) Benchmark Botanics Inc. CAD (OTCPK:BHHKF) Friday Night Inc. CAD (OTCQB:TGIFF) Valens Groworks Corp. CAD (OTC:MYMSF) Invictus MD CAD (IVITF) Emblem Corp. CAD (OTCPK:EMMBF) Tetra Bio-Pharma Inc. CAD (OTCQB:TBPMF) Maple Leaf Green World Inc. CAD (OTCQB:MGWFF) Delta 9 Cannabis Inc. CAD (OTC:VRNDF) Nutritional High International Inc. CAD (OTCQB:SPLIF) Lifestyle Delivery Systems Inc. CAD (OTCQX:LDSYF) Marapharm Ventures Inc. CAD (OTCQX:MRPHF) Wildflower Marijuana Inc. CAD (OTC:WLDFF) Indiva Ltd. CAD (OTC:RMKXD) Hempco Food And Fiber Inc. CAD (OTC:HMPPF) PUF Ventures Inc. CAD (OTCPK:PUFXF) Liberty Leaf Holdings CAD (OTCQB:LIBFF) Canada House Welln

  • [By Sean Williams]

    The next-largest cannabis producer is Aphria (NASDAQOTH:APHQF), which is expected to deliver 230,000 kilograms of fully funded capacity, per company estimates. Aphria One is a four-phase, more than $100 million project that should yield 100,000 kilograms of annual production. Meanwhile, Aphria Diamond is a partnered project with Double Diamond Farms capable of yielding 120,000 kilograms a year. The remainder is expected to come from Aphria’s acquisition of Broken Coast Cannabis.

  • [By Sean Williams]

    One such major player is Aphria (NASDAQOTH:APHQF). At the moment, Aphria is on track to be the third-largest producer by annual yield –approximately 230,0000 kilograms, by its own estimate — and it just so happens to have reported its third-quarter operating results last week. Let’s take a deeper dive into Aphria by looking at the 10 things you should know following its report.

  • [By ]

    The three companies we consider most potent for future growth in value are Canopy Growth Corp. (NYSE:CGC), Aurora Cannabis (OTCQX:ACBFF), and Aphria (OTCQB:APHQF). Canopy is a diversified cannabis company that both produces and sells cannabis products for the Canadian medical cannabis market. The company is well-positioned to start growing for recreational use once it becomes legal. Aurora’s focus is also on both growing and selling medical cannabis and produces both psychoactive THC products and medically oriented CBD products. It has an aggressive growth and acquisition strategy, also having conducted the largest acquisition in the cannabis industry when acquiring CanniMed Therapeutics earlier this year. Aphria is another grower and seller of medical marijuana, which conducts its sales through retail stores and wholesale distribution. All three companies have well-positioned themselves in the Canadian market and could be potential target companies for Big Tobacco or Big Alcohol or turn into major market leaders.

  • [By Keith Speights]

    Other Canadian marijuana growers could also jump into the fray. Last month, BNN Bloomberg reported that Molson Coors (NYSE:TAP) was in discussions with several Canadian companies, including Aurora Cannabis (NASDAQOTH:ACBFF) and Aphria (NASDAQOTH:APHQF), about collaborating on cannabis-infused beverages. The report also indicated that Molson Coors was potentially interested in investing in a Canadian marijuana grower, as Constellation Brands did.

Best Tech Stocks To Watch Right Now: ABM Industries Incorporated(ABM)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares ofABM Industries, Inc. (NYSE:ABM) jumped as much as 13.4% in trading Thursday after thefacility solutions provider reported fiscal second-quarter results that topped analyst expectations. The stock cooled off slightly at midday but was still up 11.3% at 11:05 a.m. EDT.

Hot Undervalued Stocks For 2019

Peter Krauth

After hitting a distinct bottom early in the last week, silver prices have already bounced back impressively despite ongoing U.S. dollar strength. After starting May near $16.25, the price of silver rallied to a high near $16.47 last week.

The other challenge that silver faced was the news the market awaited from the FOMC meeting on Wednesday, May 2. After the meeting, the committee announced that it would not be hiking interest rates and said inflation continues to move higher.

After peaking on Tuesday, May 1, the gold/silver ratio has quietly begun trending downward once again. I think this is in recognition of silver’s underperformance and undervalued state relative to gold.

Hot Undervalued Stocks For 2019: RELX PLC(RELX)

Advisors’ Opinion:

  • [By Max Byerly]

    Oppenheimer Asset Management Inc. decreased its position in RELX Group (NYSE:RELX) by 33.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,655 shares of the technology company’s stock after selling 13,198 shares during the period. Oppenheimer Asset Management Inc.’s holdings in RELX Group were worth $557,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Hot Undervalued Stocks For 2019: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Keith Speights]

    Should Aurora actually buy MedReleaf, there could be considerable pressure on Canopy to make an acquisition of its own. One obvious target to buy would be Aphria (NASDAQOTH:APHQF), which has roughly the same market cap as MedReleaf. But would this acquisition make sense for Canopy Growth? I think it could.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days (percentages reflect approximate equity moves as of the time of the writing of this article.

    22nd Century Group Inc (NYSE: XXII): up 4.5 percent
    Aphria Inc (OTC: APHQF): down 1.4 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.6 percent
    Cannabis Sativa Inc (OTC: CBDS): down 6.3 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.3 percent
    Canopy Growth Corp (NYSE: CGC): up 1.8 percent
    Cronos Group Inc. (NASDAQ: CRON): up 9.3 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.2 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 15.5 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 1.9 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.6 percent
    MassRoots Inc (OTC: MSRT): down 0.2 percent
    MedReleaf Corp(OTC: MEDFF): up 1.1 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.6 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 5.5 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): up 7.3 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Keith Speights]

    Most Canadian marijuana stocks, including Canopy Growth (NYSE:CGC), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF), jumped on Wednesday after the historic vote. What’s next? There will likely be five phases Canadian marijuanastocks will experience.

  • [By SEEKINGALPHA.COM]

    Yesterday we wrote that we saw rampant red flags with Aphrias (OTCQB:APHQF) proposed Nuuvera (OTC:NUUVF) transaction. In particular, the transaction seemed to make little economic or strategic sense, and we had found it worrying that a self-described Aphria advisor named Andy DeFrancesco seemed to have business dealings with both sides of the deal.

Hot Undervalued Stocks For 2019: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Exelixis (NASDAQ:EXEL) EVP Jeffrey Hessekiel sold 20,000 shares of the company’s stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $22.36, for a total transaction of $447,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Stephan Byrd]

    Exelixis, Inc. (NASDAQ:EXEL) VP Patrick J. Haley sold 3,663 shares of the business’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $21.61, for a total transaction of $79,157.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Orelli]

    Exelixis (NASDAQ:EXEL) and Bristol-Myers continue their love-hate relationship with results from a trial testing Exelixis’ Cabometyx and Opdivo in patients with urothelial carcinoma. The duo are already testing the combination in a phase 3 trial called CheckMate 9ER, so investors are looking for this updated data to give them confidence that the combination is continuing to work.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here’s why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS).

Hot Undervalued Stocks For 2019: Preferred Apartment Communities, Inc.(APTS)

Advisors’ Opinion:

  • [By Max Byerly]

    WINTON GROUP Ltd acquired a new stake in Preferred Apartment Communities Inc. (NYSE:APTS) during the 1st quarter, Holdings Channel reports. The firm acquired 80,485 shares of the real estate investment trust’s stock, valued at approximately $1,142,000.

  • [By Joseph Griffin]

    Preferred Apartment (NYSE:APTS) – Research analysts at B. Riley raised their FY2018 earnings estimates for shares of Preferred Apartment in a note issued to investors on Thursday, May 3rd. B. Riley analyst C. Kucera now expects that the real estate investment trust will post earnings per share of $1.45 for the year, up from their prior estimate of $1.44. B. Riley currently has a “Hold” rating and a $16.00 price target on the stock. B. Riley also issued estimates for Preferred Apartment’s Q4 2018 earnings at $0.40 EPS.

  • [By Ethan Ryder]

    Stratos Wealth Partners LTD. lifted its stake in shares of Preferred Apartment Communities Inc. (NYSE:APTS) by 135.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,089 shares of the real estate investment trust’s stock after purchasing an additional 8,113 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Preferred Apartment Communities were worth $200,000 as of its most recent SEC filing.

Hot Undervalued Stocks For 2019: Recon Technology, Ltd.(RCON)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Recon Technology (NASDAQ:RCON) has been trending positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Recon Technology earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned media headlines about the oil and gas company an impact score of 44.9374991541436 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Safest Stocks To Buy Right Now

The stock market’s relentless march upward has pushed the prices of many companies higher. As investors bid up good and bad businesses alike, it can be hard to discern which companies are the best for long-term investors.

That’s especially true in the world of dividend stocks, where income-starved investors face greater temptation by the day to reach for high dividend stocks that offer juicy yields.

Fortunately, Simply Safe Dividends identified 10 super-safe dividend growth stocks that investors can rely on for secure, fast-growing income.

These companies all have very healthy Dividend Safety Scores, which measure a firm’s most important financial metrics to gauge how likely it is to cut its dividend in the future.

Let’s take a look at 10 of the safest dividend growth stocks in the market. These companies generate excellent free cash flow, maintain safe payout ratios, are committed to rewarding shareholders with healthy dividend increases and have bright long-term outlooks.

Top 5 Safest Stocks To Buy Right Now: Berjaya Sports Toto Berhad (BJSAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Listed on the Malaysian Bursa and also traded over the US OTC markets (OTCPK:BJSAF), Berjaya Sports Toto (BToto) is a Malaysian company primarily engaged in toto betting, leasing of online lottery equipment, and the manufacture and distribution of computerized lottery and voting systems. As part of its diversification plans, BToto also operates a hotel in the Philippines and retails luxury motor brands in the UK.

Top 5 Safest Stocks To Buy Right Now: Veeco Instruments Inc.(VECO)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    VECO (NASDAQ:VECO) contributed 1.16% to the Fund’s quarterly return, nearly equaling AAN’s contribution in the quarter. VECO appreciated over 48% in the quarter due to an acceleration of orders for its key MOCVD tools. These tools are the main manufacturing equipment used to produce LEDs, whether they are for display screens or, increasingly, for lighting products. We estimate that VECO currently has roughly 80% global market share for MOCVD tools used to make LEDs.

  • [By Paul Ausick]

    Veeco Instruments Inc. (NASDAQ: VECO) dropped nearly 26% Friday to post a new 52-week low of $10.85 after closing at $14.65 on Thursday. The 52-week high is $34.38. Volume was around 5.8 million, about 10 times the daily average of around 584,000. The company reported late yesterday that it had received an unfavorable patent ruling in China.

  • [By Lisa Levin]

    Thursday afternoon, the information technology sector proved to be a source of strength for the market. Leading the sector was strength from QuickLogic Corporation (NASDAQ: QUIK) and Veeco Instruments Inc. (NASDAQ: VECO).

Top 5 Safest Stocks To Buy Right Now: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Javier Hasse]

    While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.

  • [By SEEKINGALPHA.COM]

    Aphria (OTCQB:APHQF) just did something very unusual and frankly caught us by surprise. The company announced that it is amending its previously announced transaction with Nuuvera (OTC:NUUVF) by which the cash portion of the consideration will be lowered from $1.00 to $0.60. The announcement surprised us as our past experience suggested that lowering purchase price post-deal announcement is extremely uncommon, especially in the absence of major negative developments at the target. Simultaneously, Nuuvera announced that it is acquiring the remaining 49% minority interest in Avanti Rx Analytics from a minority shareholder for $43 million. Avanti is a subsidiary of Nuuvera that provides research and testing services for cannabis companies. Nuuvera claimed that the reduced cash offer helps fund its acquisition, which makes no sense for us.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

  • [By Keith Speights]

    There are plenty of reasons for investors to like three marijuana stocks in particular — GW Pharmaceuticals (NASDAQ:GWPH), Insys Therapeutics (NASDAQ:INSY), and Aphria (NASDAQOTH:APHQF). In fact, there are at least 661 million reasons. That’s the amount of cash in U.S. dollars that the three companies have combined. Here’s why the cash stockpiles held by GW, Insys, and Apria are important.

  • [By Todd Campbell]

    While some marijuana companies are turning a profit, many marijuana companies are investing heavily in their businesses, and as a result, continue to lose money. For example, Aphria Inc. (NASDAQOTH:APHQF), a Canadian producer and marketer of medical marijuana, reported a net profit of $1 million over the past 12 months, but medical-marijuana drug developer GW Pharmaceuticals plc (NASDAQ:GWPH) reported a loss of $82.2 million last fiscal year.

Top 5 Safest Stocks To Buy Right Now: Packaging Corporation of America(PKG)

Advisors’ Opinion:

  • [By Christopher Freeburn]

    Shares of Packaging Corp. (PKG) jumped almost 13% in pre-market trading on Monday after the company announced that it will purchase a rival containerboard-maker.

  • [By David Sterman]

    That was precisely the rationale behind Packaging Corp. of America's (NYSE: PKG) just-announced $2 billion (in cash and assumed debt) acquisition of rival Boise (NYSE: BZ). The deal will create a $6 billion (in sales) behemoth in the cardboard box industry.

  • [By Daniela Pylypczak]

    Jefferies announced on Monday that it has upgraded Packaging Corp of America (PKG) from “Hold” to “Buy.”

    The firm also raised PKG’s price target from $49.00 to $70.00. Jefferies analystPhilip Ng also gave the companybull-case scenario target of $88. The upgrade comes after the firm announced earlier today that it has agreed to purchase all outstanding shares of Boise Inc. (BZ)for $1.995 billion. Analyst Ng believes the new acquisition will result in an attractive multiple.

    Packaging Corp of America shares rallied 9.73% during Monday’s session. Year-to-date, the stock is up 39.87%.

Top 5 Safest Stocks To Buy Right Now: Liberty Interactive Corporation(LVNTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of General Communication, Inc. (NASDAQ: GNCMA) got a boost, shooting up 63 percent to $33.43 after Liberty Interactive Corporation (NASDAQ: LVNTA) announced plans to acquire General Communication for $1.12 billion.

Top 10 Warren Buffett Stocks To Invest In 2018

On Feb. 17, 2017, the U.S. total market cap / gross domestic product ratio reached 130%, a critical milestone as valuations remain significantly overvalued. Most of Warren Buffett (Trades, Portfolio)’s portfolio holdings as of Dec. 31, 2016, have price-sales valuations greater than the 80th percentile of the industry. Such companies include The Coca-Cola Co. (NYSE:KO), International Business Machines Corp. (NYSE:IBM), Delta Air Lines Inc. (NYSE:DAL), Apple Inc. (NASDAQ:AAPL) and Southwest Airlines Co. (NYSE:LUV).

Buffett indicator reaches critical milestone

Buffett pointed out that the ratio of the Wilshire 5000 full-cap index over the gross domestic product is “probably the best single measure of where valuations stand at any given moment.” The total market index is currently $24513.4 billion, about 130% of the last reported U.S. GDP. Such market valuations seldom appeared since the dot-com bubble of 2000, when the Buffett indicator reached nearly 150%. Figure 1 shows the historical trendline of the Buffett indicator since 1970.

Top 10 Warren Buffett Stocks To Invest In 2018: Fresh Del Monte Produce, Inc.(FDP)

Advisors’ Opinion:

  • [By Lee Jackson]

    The man at the top of Fresh Del Monte Produce Inc. (NYSE: FDP) wasselling stock last week. Chairman and CEO Mohammad Abu-Ghazaleh shed a block of 50,000 shares at prices that ranged from $57.85 to $58.46 apiece. The total was listed at $2.9 million. The stock ended the weekat $58.31, in a 52-week range of $41.70 to $66.86. The consensus price target is $70.30.

  • [By John Udovich]

    Thanksgiving is almost here and aside from featuring a turkey, most Thanksgiving dinners will include items from a range of consumer stocks including Campbell Soup Company (NYSE: CPB), Kraft Heinz Co (NASDAQ: KHC), Fresh Del Monte Produce Inc (NYSE: FDP) and McCormick & Company (NYSE: MKC) along with aThanksgiving turkey from Hormel Foods Corporation (NYSE: HRL)or Seaboard Corporation (NYSEAMEX: SEB). According tothe American Farm Bureau Federation,a classic Thanksgiving dinner will cost$49.87 for a gathering of 10 orjust under $5 per person down from 2015s all-time high of $50.11.

Top 10 Warren Buffett Stocks To Invest In 2018: Orbital ATK, Inc.(OA)

Advisors’ Opinion:

  • [By Rich Smith]

    While Trump’s nuclear tweet appears to have taken some folks off guard, the fact is that the U.S. has been planning a major upgrade and refurbishmentof its nuclear arsenal for quite some time — since at least the early years of the second Obama administration, in fact. As far back as three years ago, we were writing about a U.S. Air Force effort to begin upgrading the nation’s aging fleet of Minuteman III intercontinental ballistic missiles — a contract that Aerojet Rocketdyne (NYSE:AJRD), among others, is counting on to juice its rocket revenues. Rival rocket scientist Orbital ATK (NYSE:OA) is bidding on the same contract, and whether it’s Aerojet or Orbital that eventually ends up winning this piece of the nuclear rearmament project, there should be money aplenty to go around.

  • [By Rich Smith]

    Orbital ATK (NYSE:OA) occupies a charmed space in the U.S. market for putting satellites in, er, space.

    At one end of the space launch continuum, you have United Launch Alliance, whose Delta IV Heavy launch vehicle, developed by Boeing (NYSE:BA), can put a payload massing in excess of 28 tonsinto orbit in a single launch — at a cost of $350 million.At the other end, new space start-ups like Vector Space are promising to launch a new generation of small satellites into low-earth orbit for prices as little as $2 million a shot. But what about the middle?

  • [By Rich Smith]

    Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).

  • [By Lisa Levin]

    Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.

  • [By Jim Robertson]

    Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.

Top 10 Warren Buffett Stocks To Invest In 2018: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

  • [By Chris Dier-Scalise]

    On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

Top 10 Warren Buffett Stocks To Invest In 2018: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

Top 10 Warren Buffett Stocks To Invest In 2018: Black Diamond, Inc.(BDE)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggested small cap sporting & outdoor goods stock Black Diamond Inc (NASDAQ: BDE) as a short/bearish trade:

Top 10 Warren Buffett Stocks To Invest In 2018: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

Top 10 Warren Buffett Stocks To Invest In 2018: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    J P Morgan Chase & Co (NYSE: JPM): Free Stock Analysis Report
     
    Comerica Incorporated (NYSE: CMA): Free Stock Analysis Report
     
    Wells Fargo & Company (NYSE: WFC): Free Stock Analysis Report
     
    Citigroup Inc. (NYSE: C): Free Stock Analysis Report
     
    Wintrust Financial Corporation (NASDAQ: WTFC): Free Stock Analysis Report
     
    Synovus Financial Corp. (NYSE: SNV): Free Stock Analysis Report
     
    State Bank Financial Corporation. (NASDAQ: STBZ): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Warren Buffett Stocks To Invest In 2018: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    When I began writing this, I had a 76% unrealized gain on my position in Aphria Inc (OTCQB:APHQF). It’s crunch time. This is where most sane individuals would be jumping ship and taking earnings. Me? I’m tempted to stay. Aphria has big things happening. The ramifications of the their developing marketplace in Canada are giving Aphria the potential to start reeling in some serious revenues. Furthermore, they have significant holdings in the United States that offer upside if regulatory hurdles don’t get in the way.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    Aphria (OTCQB:APHQF) just did something very unusual and frankly caught us by surprise. The company announced that it is amending its previously announced transaction with Nuuvera (OTC:NUUVF) by which the cash portion of the consideration will be lowered from $1.00 to $0.60. The announcement surprised us as our past experience suggested that lowering purchase price post-deal announcement is extremely uncommon, especially in the absence of major negative developments at the target. Simultaneously, Nuuvera announced that it is acquiring the remaining 49% minority interest in Avanti Rx Analytics from a minority shareholder for $43 million. Avanti is a subsidiary of Nuuvera that provides research and testing services for cannabis companies. Nuuvera claimed that the reduced cash offer helps fund its acquisition, which makes no sense for us.

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

Top 10 Warren Buffett Stocks To Invest In 2018: Mitel Networks Corporation(MITL)

Advisors’ Opinion:

  • [By Lisa Levin]

    ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.

Top 10 Warren Buffett Stocks To Invest In 2018: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.